The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 254.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.704%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 254.00
MAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Sep 2017 09:40

RNS Number : 2709R
Maintel Holdings PLC
20 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

MAINTEL HOLDINGS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

18 SEPTEMBER 2017

6. Date on which issuer notified (DD/MM/YYYY):

19 SEPTEMBER 2017

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

16.1699%

 

16.1699%

14,197,059

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B046YG73

 

2,295,649

 

16.1699%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

2,295,649

16.1699%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Canaccord Genuity Group Inc.

16.1699%

 

16.1699%

 

 

 

 

Canaccord Genuity Wealth Group Holdings Limited

16.1699%

 

16.1699%

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

16.1699%

 

16.1699%

 

 

 

 

Hargreave Hale Limited

16.1699%

 

16.1699%

 

 

 

 

[1] Each company set out in this table is ultimately owned by Canaccord Genuity Group Inc.

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

This disclosable event is as a result of the acquisition of Hargreave Hale Limited by Canaccord Genuity Group Inc., through its wholly-owned subsidiary Canaccord Genuity Wealth Group Holdings (Jersey) Limited.

 

 

     

 

Place of completion

London

Date of completion

19 September 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUROWRBKAKURR
Date   Source Headline
18th Apr 202412:30 pmRNSBoard Changes
18th Apr 20247:00 amRNSNotice of Final Results
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSBoard Changes
22nd Jan 20247:00 amRNSTrading Update and Notice of Results
16th Oct 20234:15 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSDirector/PDMR Shareholding
19th Sep 20231:34 pmRNSReplacement: Interim results
19th Sep 20237:00 amRNSInterim results
4th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading update and Notice of Results
30th May 20235:25 pmRNSResults of AGM and Board Changes
30th May 20231:03 pmRNSAGM Statement
11th May 20232:20 pmRNSDirector Appointment
4th May 20235:15 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSGrant and Surrender of Options
27th Apr 20237:00 amRNSFinal Results
17th Feb 20239:46 amRNSDirectorate Change
19th Jan 20233:33 pmRNSTrading Update
1st Nov 20227:00 amRNSBoard Update
29th Sep 20227:00 amRNSInterim Results
9th May 20224:15 pmRNSResult of AGM
5th May 20221:30 pmRNSGrant of Options
25th Apr 20223:55 pmRNSHolding(s) in Company
13th Apr 20224:30 pmRNSNotice of AGM
7th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSGrant of Options
31st Mar 20227:00 amRNSFinal Results
25th Mar 20227:00 amRNSRefinancing Agreement with HSBC UK
18th Mar 20228:20 amRNSHolding(s) in Company
31st Jan 20227:30 amRNSTrading Update
28th Oct 202112:20 pmRNSHolding(s) in Company
25th Oct 20214:20 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSDirector Appointment
7th Sep 20217:00 amRNSInterim Results
3rd Sep 20214:37 pmRNSHolding(s) in Company
31st Aug 202112:30 pmRNSBoard Update and Notice of Results
30th Jun 20211:09 pmRNSResult of AGM//Board Change
2nd Jun 20212:06 pmRNSSecond Price Monitoring Extn
2nd Jun 20212:00 pmRNSPrice Monitoring Extension
2nd Jun 202111:05 amRNSSecond Price Monitoring Extn
2nd Jun 202111:00 amRNSPrice Monitoring Extension
2nd Jun 20219:05 amRNSSecond Price Monitoring Extn
2nd Jun 20219:00 amRNSPrice Monitoring Extension
2nd Jun 20217:00 amRNSBoard Changes
2nd Jun 20217:00 amRNSFinal Results
30th Apr 20214:10 pmRNSCompletion of Sale
18th Mar 20217:00 amRNSSale of Managed Print Services Business Unit
3rd Feb 20213:00 pmRNSGrant of Options
25th Jan 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.